Drug R & D
——
Drug R & D
Indications
Hepatocellular carcinoma (HCC)
Liver cancer is the fourth most common cancers and the second leading cause of cancer deaths in China, 2018. HCC, accounting for up to 85-90% of liver cancer, is one of the deadliest cancers and is ranked as the third most common cause of cancer-related deaths worldwide.
Breast cancer
Breast cancer is the most common malignancy and the leading cause of cancer death among women worldwide. Although lower than the global average, breast cancer has already become the highest incidence cancer in women in China, accounting for 17% of female malignancies, and with a clear upward trend.
address：
A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176
phone：
Copyright ©2019 BroadenBio